Patients’ selection and trial matching in early-phase oncology clinical trials
Authors:
Open Access
- 23 February 2024
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 196, 104307
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (20023)
- Université Claude Bernard Lyon 1
- Institut National Du Cancer
This publication has 68 references indexed in Scilit:
- ESMO study on the availability and accessibility of biomolecular technologies in oncology in EuropeAnnals of Oncology, 2023
- Searching for clinical trials in oncology: finding a path through the mazeAnnals of Oncology, 2023
- MatchMiner open‐source platform matches patients with cancer to precision medicine trialsCancer, 2023
- Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes studyAnnals of Oncology, 2022
- Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemicCancer Cell, 2021
- Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer CenterInternational Journal of Cancer, 2020
- An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohortAnnals of Oncology, 2020
- Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A reviewContemporary Clinical Trials Communications, 2018
- ConSoRe : un outil permettant de rentrer dans le monde du big data en santéBulletin du Cancer, 2016
- Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical TrialsJAMA, 2004